Life Sense

What Life Sense does

Life Sense (Guangdong Lifesense Medical Electronics Co., Ltd., SZSE: 300562) is a China-based public medical device and digital health company that designs, manufactures, and sells medical-grade health monitoring hardware integrated with AI-powered chronic disease management software and services. Founded in 2000 and listed on the Shenzhen Stock Exchange in November 2016, the company operates from Shenzhen (headquarters and marketing), Zhongshan (manufacturing center), Shanghai (algorithm R&D), Hong Kong (global marketing), and San Jose, California (R&D).

The product portfolio spans six hardware categories: smart body composition scales (S21, A12, A30, A22, A7, S30) using BIA technology; smart wearables including Smart Band 6s, Smart Band 9, and Smart Watch WATCH 3; medical-grade wearable ECG monitors (iSENSE-800T) capable of 24-hour continuous monitoring for atrial fibrillation and myocardial ischemia; home blood pressure monitors (S217) and blood glucose meters (GLM-73, GLM-76); and OTC hearing aids (Mercury). Underlying technologies include proprietary G-sensors, ANC/ENC acoustic processing, BIA, multiple health data algorithms, and a chronic disease management AI model that generates personalized intervention plans from multi-dimensional monitoring data. The platform architecture is positioned as a 'hardware + sensing + algorithms + big data + AI + cloud computing + services' full-chain capability matrix, with the company holding medical device certifications in 20+ countries (FDA, EU MDR, NMPA, ISO 13485) and 25+ system certifications.

Life Sense generates revenue through three primary streams: (1) consumer hardware sales via Tmall, JD.com, and the Lifesense app; (2) enterprise/B2B sales of digital chronic disease management solutions to healthcare institutions, elderly care facilities, corporate wellness programs, and insurance companies; and (3) international distribution developed through major medical exhibitions and overseas sales teams. The May 2025 strategic partnership with Ping An Health Internet extends the model into an integrated 'prevention-monitoring-intervention' closed-loop system combining remote ECG and blood pressure monitoring with online medical consultations. Customer segments span post-cardiovascular surgery patients, chronic disease and sub-health populations, fitness consumers, corporate wellness clients, and healthcare institutions. Q1 2025 revenue was RMB 273M with net profit of RMB 22.94M.

Name

Life Sense

Legal name

广东乐心医疗电子股份有限公司 (Guangdong Lifesense Medical Electronics Co., Ltd.)

Website

https://lifesense.com

Company type

Public

Founded year

2000

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Life Sense (SZSE: 300562) is a China-based public medical device company that designs, manufactures, and sells medical-grade health monitoring hardware (ECG, blood pressure, glucose, body composition, wearables, hearing aids) integrated with AI-powered digital chronic disease management software and services for consumers, healthcare institutions, and corporate wellness clients globally.

Ownership category

akta.pro rank

Product category

Medical Wearable Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Chronic Condition Management & Remote Monitoring (e.g., diabetes, HTN) (HLALADAD)

akta.pro secondary industries

Connected Medical Devices & Wearables (Sensors, Patches, Implantables) (HLACAPAB), Health Monitoring Wearables (ECG, BP, SpO2, CGM-compatible) (CRACAIAF), ECG/EKG & Heart Rhythm Monitors (Consumer) (CRACAQAC), Blood Glucose Monitoring Devices (Consumer CGM & Smart Glucometers) (CRACAQAE), Smart Fitness & Training Devices (Connected Fitness Sensors, Smart Jump Ropes, etc.) (CRACAQAH)

Keywords

• Medical wearable devices
• Remote patient monitoring
• Digital chronic disease management
• Health monitoring hardware
• Connected medical devices

Headquarters

HQ city

Guangzhou

HQ country

China

HQ region

Asia

Offices5 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Operations, Personnel, Marketing or Sales, Others

Revenue model

1. Medical-grade Health Monitoring Hardware Sales: Sale of medical devices including blood pressure monitors, blood glucose meters, ECG monitoring equipment, smart scales, wearables (smartwatches, fitness bands), and hearing aids. Products sold through direct sales teams, e-commerce platforms (Tmall, JD.com), and international distribution channels.
2. Digital Health Services and Software: AI-powered remote chronic disease management services, real-time health monitoring data analysis, personalized intervention plans, and cloud-based health management platform subscriptions integrated with hardware sales.
3. Enterprise/B2B Solutions: Corporate wellness management solutions and enterprise employee health monitoring services targeting insurance companies and corporate clients, delivered through strategic partnerships like the one with Ping An Health.

Pricing tiers

Go-to-market motion2 records

Distribution channels5 records

Marketing channels5 records

Core offering

Life Sense designs, manufactures, and sells medical-grade wearable health monitoring devices including smart body fat scales, smartwatches/fitness bands, home ECG monitors, blood pressure monitors, blood glucose meters, and OTC hearing aids. The company combines this hardware with an AI-powered digital chronic disease management platform that delivers remote monitoring, anomaly detection, and personalized intervention plans for cardiovascular, metabolic, and lifestyle-related conditions. Its solutions are sold to both individual consumers via e-commerce and to healthcare institutions, insurance companies, and corporate wellness programs via direct enterprise sales.

Product overview

Lifesense (乐心医疗) operates as a digital chronic disease management solution provider with a portfolio of medical-grade health monitoring hardware and digital health services. The product portfolio consists of six main hardware categories: (1) Smart body fat scales (S21, A12, A30, A22, A7, S30) for weight and body composition monitoring; (2) Smart sports wearables including Smart Band 6s, Smart Band 9, and Smart Watch WATCH 3 for activity and health tracking; (3) Home ECG monitoring devices including the iSENSE-800T wearable dynamic ECG monitor; (4) Home blood glucose meters (GLM-73, GLM-76) for diabetes management; (5) Smart hearing aids (Mercury OTC hearing aid); and (6) Medical automatic electronic sphygmomanometers. The company also provides digital chronic disease management services powered by AI, including remote dynamic ECG monitoring and digital blood pressure management services, creating a closed-loop system combining "hardware + sensing + algorithms + big data + AI + cloud services."

Differentiator

Problem solved

Functional benefit

Products and services

• Smart Body Fat Scales (S21, A12, A30, A22, A7, S30) Connected body composition scales using BIA technology for home weight, body fat, and heart rate monitoring, with app-based long-term health tracking for individual consumers and chronic disease populations.
• Smart Wearable Bands (Smart Band 6s, Smart Band 9) and Smart Watch WATCH 3 Smartwatches and fitness bands providing activity tracking, heart rate, blood oxygen, stress, sleep monitoring, and over 100 exercise modes for general consumers and fitness users.
• Wearable Dynamic ECG Monitor iSENSE-800T Medical-grade home ECG monitoring device for continuous 24-hour or extended cardiac monitoring, detecting atrial fibrillation and myocardial ischemia, providing full-cycle screening, monitoring, diagnosis, and rehabilitation services.
• Blood Glucose Meters (GLM-73, GLM-76) Home-use blood glucose meters for diabetic patients, with app connectivity for data tracking and chronic disease management.
• OTC Hearing Aid Mercury Over-the-counter hearing aid with ANC/ENC noise cancellation, providing personalized sound amplification for individuals with hearing impairment.
• Medical Automatic Electronic Sphygmomanometer S217 Medical-grade automatic electronic blood pressure monitor for home use, with no-cuff arm band, posture correction, and dynamic data collection, sold via Tmall and JD.com.
• Digital Chronic Disease Management Solution Integrated digital chronic disease management service combining medical-grade hardware, AI-powered data analysis, real-time anomaly alerts, and personalized intervention plans for cardiovascular, metabolic, and lifestyle conditions; delivered to healthcare institutions, insurance companies, corporate wellness programs, and elderly care facilities.

Quantifiable outcome

• Q1 2025 revenue: RMB 273 million (9.90% YoY growth)
• +1 more outcomes

Named customers5 records

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability6 records

Feature7 records

Partnerships

One partnership is on record.

• Ping An Health (平安健康互联网股份有限公司)coreStrategic or Co-development Partner · 21 May 2025Strategic partnership announced on May 21, 2025 to build a full-chain health management model of 'prevention-monitoring-intervention'. The partnership combines Lifesense's remote dynamic ECG services and digital blood pressure management technology with Ping An Health's online medical services and health management resources, focusing on heart attack and stroke prevention. The collaboration will expand to cover blood glucose, blood pressure, weight management and other health dimensions.

Scale indicators8 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Omron Healthcare: Omron is the global leader in home blood pressure monitors and a major player in connected health devices (smart scales, activity trackers, ECG). It competes head-to-head with Life Sense in medical-grade home monitoring and is the primary benchmark for the BP monitor and smart scale product lines.
• Withings: Withings (Nokia-owned) sells connected health devices including smart scales, blood pressure monitors, hybrid smartwatches, and sleep analyzers, with companion apps for chronic condition tracking. Directly comparable to Life Sense on smart body composition scales, connected BP monitors, and consumer-to-medical-grade wearables.
• iRhythm Technologies: iRhythm's Zio long-term continuous ECG monitoring patch and AI-based arrhythmia detection platform is a direct analog to Life Sense's iSENSE-800T 24-hour dynamic ECG monitor plus cardiovascular AI model. Both target remote cardiac monitoring with algorithmic interpretation.
• Ypsomed: Ypsomed is a leading diabetes care platform with connected insulin pens, blood glucose meters, and a digital diabetes management ecosystem—directly comparable to Life Sense's GLM-73/76 glucose meters and the chronic disease management platform built around glucose data.

Broad incumbents

• Philips: Philips has a broad portfolio spanning patient monitoring, connected wearables, sleep and respiratory care, and population health management. Overlaps with Life Sense on remote patient monitoring hardware and digital chronic disease management, but as part of a much larger medtech portfolio.
• Huawei Device: Huawei sells smartwatches (Watch GT, Watch Fit) and smart bands with ECG, SpO2, heart rate, and stress monitoring—directly competing with Life Sense's WATCH 3 and Smart Band 6s/9 in consumer wearables, while also serving enterprise health programs in China.
• Xiaomi: Xiaomi's Mi Band, Mi Watch, and Mi Smart Scale product lines compete aggressively with Life Sense in Chinese consumer wearables and smart scales, often at lower price points. Both serve as China-domiciled consumer health device brands with e-commerce-led distribution.
• Garmin: Garmin's vivoactive, Venu, and fēnix smartwatch lines plus Index smart scales compete with Life Sense on health-monitoring wearables with strong international distribution, particularly in sports, fitness, and increasingly health-focused segments.
• Apple (Apple Health / Apple Watch): Apple Watch with ECG, blood oxygen, heart rate, and atrial fibrillation detection—and the broader Apple Health ecosystem—competes with Life Sense's wearable lines and increasingly encroaches on consumer-grade health monitoring use cases Life Sense has historically served.

Emerging players

• Dexcom: Dexcom is the leading continuous glucose monitor (CGM) provider with a connected diabetes management platform. Comparable to Life Sense on the diabetes management vertical, though Dexcom operates at a more advanced sensor tier and is the natural escalation path if Life Sense expands into CGM.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Compliance10 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Life Sense